MedTrace Logo

Fertility After Intrauterine Tamponing Balloon: Where Are we

NCT04133402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2020-07-01

No results posted yet for this study

Summary

Today, few data are available on the patient's fertility following intrauterine tamponade balloon (BTIU) used for postpartum hemorrhage (PPH) after vaginal delivery (AVB). Several studies have concluded that there are no fertility disorders after conservative surgical treatment or embolization. BTIU is an essential treatment in the management of PPH. The aim was to evaluate post-BTIU fertility and the appearance of gynecological symptoms.

This is a bicentric retrospective study (Valenciennes, Lille, France), between 2012 and 2017. The data will be collected by telephone interview on fertility and various gynecological functional symptoms.

Conditions

  • Hemorrhage Postpartum
  • Fertility Disorders

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Charles Garabedian, MD,PhD · University Hospital, Lille

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-19
Primary Completion
2019-12-27
Completion
2019-12-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04133402 on ClinicalTrials.gov